Abstract:Abstract Hereditary spastic paraplegias (HSPs) are characterized by lower limb spasticity resulting from degeneration of long corticospinal axons. SPG11 is one of the most common autosomal recessive HSPs, and the SPG11 protein spatacsin forms a complex with the SPG15 protein spastizin and heterotetrameric AP5 adaptor protein complex, which includes the SPG48 protein AP5Z1. Using the integration-free episomal method, we established SPG11 patient-specific induced pluripotent stem cells (iPSCs) from patient fibroblasts. We differentiated SPG11 iPSCs, as well as SPG48 iPSCs previously established, into cortical projection neurons (PNs) and examined protective effects by targeting mitochondrial dynamics using P110, a peptide that selectively inhibits mitochondrial fission GTPase Drp1. P110 treatment mitigates mitochondrial fragmentation, improves mitochondrial motility, and restores mitochondrial health and ATP levels in SPG11 and SPG48 neurons. Neurofilament (NF) aggregations are increased in SPG11 and SPG48 axons, and these are also suppressed by P110. Similarly, P110 mitigates NF disruption in both SPG11 and SPG48 knockdown cortical PNs, confirming the contribution of HSP gene deficiency to subsequent NF and mitochondrial defects. Strikingly, NF aggregations in SPG11 and SPG48 deficient neurons double stain with ubiquitin and autophagy related proteins, resembling the pathological hallmark observed in SPG11 autopsy brain sections. To confirm the cause-effect relationship between the SPG11 mutations and disease phenotypes, we knocked-in SPG11 disease mutations to human embryonic stem cells (hESCs) and differentiated these stem cells into cortical PNs. Reduced ATP levels and accumulated NF aggregations along axons are observed, and both are mitigated by P110. Furthermore, rescue experiment with expression of wildtype SPG11 in cortical PNs derived from both SPG11 patient iPSCs and SPG11 disease mutation knock-in hESCs leads to rescue of mitochondrial dysfunction and NF aggregations in these SPG11 neurons. Finally, in SPG11 and SPG48 long-term cultures, increased release of phosphoNF-H, a biomarker for nerve degeneration, is significantly reduced by inhibiting mitochondrial fission pharmacologically using P110 and genetically using Drp1 shRNA. Taken together, our results demonstrate that impaired mitochondrial dynamics underlie both cytoskeletal disorganization and axonal degeneration in SPG11 and SPG48 neurons, highlighting the importance of targeting these pathologies therapeutically.

Spastin regulates ER-mitochondrial contact sites and mitochondrial homeostasis

Novel Mutations in the SPAST Gene Cause Hereditary Spastic Paraplegia.

[Spastin Gene Mutation in Chinese Patients with Hereditary Spastic Paraplegia].

Phosphorylation of Spastin Promotes the Surface Delivery and Synaptic Function of AMPA Receptors

Unraveling Isoform Complexity: The Roles of M1‐ and M87‐Spastin in Spastic Paraplegia 4 (SPG4)

Molecular and Cellular Mechanisms of Spastin in Neural Development and Disease (Review)

Defects in ER–endosome contacts impact lysosome function in hereditary spastic paraplegia

FBXL17/spastin axis as a novel therapeutic target of hereditary spastic paraplegia

A major disease-related point mutation in spastin alters dramatically the dynamics and allostery of the motor

Mutation of Spastin Affects Microtubule Dynamics Through Differential Distribution

A Novel SPAST Mutation Results in Spastin Accumulation and Defects in Microtubule Dynamics

Cul-4 inhibition rescues spastin levels and reduces defects in hereditary spastic paraplegia models

Inhibiting mitochondrial fission rescues degeneration in hereditary spastic paraplegia neurons

Different Fusion Tags Affect the Activity of Ubiquitin Overexpression on Spastin Protein Stability

Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis

Spastin accumulation and motor neuron defects caused by a novel SPAST splice site mutation

Spastin Interacts with CRMP2 to Regulate Neurite Outgrowth by Controlling Microtubule Dynamics Through Phosphorylation Modifications

Spastin Interacts with CRMP5 to Promote Neurite Outgrowth by Controlling the Microtubule Dynamics.

Atlastin-1 regulates endosomal tubulation and lysosomal proteolysis in human cortical neurons

Spastin Interacts with Collapsin Response Mediator Protein 3 to Regulate Neurite Growth and Branching

Rab3A Interacts with Spastin to Regulate Neurite Outgrowth in Hippocampal Neurons